Konferansen er blitt en svært viktig møteplass for internasjonale krefteksperter, norske klinikere og norsk legemiddelindustri. I år er det 15. gangen Cancer Crosslinks arrangeres

Cancer Crosslinks 2023 går av stabelen 26. januar ved Oslo Cancer Cluster Innovation Park. Programmet inkluderer internasjonale eksperter som deler de siste fremskrittene innen presisjonsmedisin og immunonkologi.

Det fagllige programmet kompletteres med en nettverkssamling på ettermiddagen der man kan knytte nye forbindelser i onkologimiljøet og utveksle ideer med snakke med kolleger. For påmelding se Oslo Cancer Cluster sine nettsider:

Ekspertpanelet Cancer Crosslinks 2023

Douglas Hanahan, Distinguished Scholar ved Ludwig Institute for Cancer Research (Zurich/New York) og professor i molekylær onkologi ved Swiss Institute for Experimental Cancer Research vil vil holde en digital tale med tame: The Hallmarks of Cancer: New Dimensions – Integrating Pre-Clinical and Clinical Cancer Trials of Mechanism-Targeted Therapies.

Mariam Jamal-Hanjani, er gruppeleder ved Cancer Metastasis Lab, CRUK Lung Cancer Center of Excellence, UCL Cancer Institute; Senior Clinical Lecturer og Honorary Consultant in Translational Lung Oncology, UCL Hospital, London, UK. Hun vil holde foredraget The natural history of non-small cell lung cancer evolution in TRACERx

Nilofer Azad, Co-Director of Cancer Genetics and Epigenetics, Professor of Oncology, Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA vil holde et digitalt foredrag om Epigenetic (Combination) Therapy – exploiting complex biology to offer novel treatment options for patients with GI cancers.

Alpaslan (Aslan) Tasdogan, Associate Professor, German Cancer Consortium (DKTK), Institute for Tumor Metabolism, Department of Dermatology, University Hospital Essen, Germany vil holde foredraget The metabolic regulation of cancer progression.

Thomas Nerreter, Junior Group Leader, Chair of Cellular Immunotherapy, Translational CAR-T Research Program, University Hospital and CCC Würzburg, Germany vil holde foredraget Cellular Therapy for solid and hematological tumors: novel targets and technologies.

Tom Erkers, Assistant Professor, Karolinska Institute, Stockholm, Sweden skal holde foredraget Data-driven hallmarks of acute myeloid leukemia: biological, prognostic & therapeutic implications.

Jakob Nikolas Kather, Professor of Clinical Artificial Intelligence, Else Kröner Fresenius Center for Digital Health, Technical University Dresden; Germany holder foredraget AI biomarkers in cancer: recent progress and the way to clinical implementation.